Legal Representation
Attorney
Edward P. Bakos
USPTO Deadlines
Next Deadline
1518 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-12)
Due Date
September 12, 2029
Grace Period Ends
March 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 12, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Sep 12, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 23, 2023 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
May 16, 2023 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
May 15, 2023 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
May 15, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 11, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
May 11, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
May 11, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 11, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 8, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 31, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jan 31, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jan 31, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 11, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 11, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 30, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
Sep 30, 2022 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
Sep 29, 2022 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
Jun 10, 2022 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
Jun 10, 2022 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
Jun 3, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jun 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 3, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jan 5, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 3, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in the nature of molecular moiety used to affect a genetic sequence in order to achieve a desired phenotypic outcome in living organisms, namely, for use in treating diseases including cancer, metabolic, cardiovascular, immunity, inflammation, and neurodegeneration
First Use Anywhere:
Mar 10, 2022
First Use in Commerce:
Mar 10, 2022
Class 009
Recorded software for storing, handling, analyzing, and interpreting genetic data to match living organisms' phenotypes to their underlying genes and/or genetic features and for designing molecular moeties to affect them; integrated circuits containing programs for audio, video and computer data processing; pre-recorded and downloaded sounds, images and data containing content in the fields of genetics and genomics
First Use Anywhere:
May 10, 2022
First Use in Commerce:
May 10, 2022
Class 042
Design of tools, namely, molecular moieties in the nature of peptides, nucleotides, small molecules used to affect genetic sequences in order to achieve a desired phenotypic outcome in living organisms
First Use Anywhere:
May 10, 2022
First Use in Commerce:
May 10, 2022
Classification
International Classes
005
009
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"GENETIC"